Acarbose for Healthy Subjects

Phase-Based Progress Estimates
3
Effectiveness
3
Safety
Healthy SubjectsAcarbose - Drug
Eligibility
18 - 60
All Sexes
What conditions do you have?
Select

Study Summary

This trial is looking at how different concentrations of saliva affect people's ability to taste glucose polymers, and how this affects their eating habits.

Treatment Effectiveness

Effectiveness Progress

3 of 3
This is further along than 93% of similar trials

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: up to 5 years

up to 5 years
Detection of glucose polymers in the presence of acarbose

Trial Safety

Safety Progress

3 of 3
This is further along than 85% of similar trials

Side Effects for

Metformin + Acarbose 50 mg
17%Flatulence
4%Urinary tract infection
This histogram enumerates side effects from a completed 2016 Phase 4 trial (NCT02049814) in the Metformin + Acarbose 50 mg ARM group. Side effects include: Flatulence with 17%, Urinary tract infection with 4%.

Trial Design

1 Treatment Group

Acarbose
1 of 1

Experimental Treatment

300 Total Participants · 1 Treatment Group

Primary Treatment: Acarbose · No Placebo Group · Phase 4

Acarbose
Drug
Experimental Group · 1 Intervention: Acarbose · Intervention Types: Drug
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Acarbose
FDA approved

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: up to 5 years

Who is running the clinical trial?

Oregon State UniversityLead Sponsor
44 Previous Clinical Trials
8,065 Total Patients Enrolled
Juyun LimPrincipal Investigator - Oregon State University
Oregon State University
1 Previous Clinical Trials
19 Total Patients Enrolled

Eligibility Criteria

Age 18 - 60 · All Participants · 1 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:

Who else is applying?

What state do they live in?
Oregon100.0%
How old are they?
18 - 65100.0%
What site did they apply to?
Department of Food Science and Technology100.0%
What portion of applicants met pre-screening criteria?
Met criteria100.0%